If not the world’s leading gene therapy research center, Nationwide Children’s Hospital seeks to aggressively expand into gene therapy research with the launch of a $74 million biotechnology manufacturing facility for genetic material used in research and clinical...
To date, the U.S. Food and Drug Administration (FDA) has approved four gene therapy products, which insert new genetic material into a patient’s cells. The agency expects a boom in gene therapy product approvals in the coming decade as evidenced by the more than 900...
The UK’s Cell and Gene Catapult (CGT Catapult) completed six additional production modules in a bid for the UK to remain competitive in the booming cell and gene therapy drug development business. The first six clean room at capacity due to high demand at the...
Lisa Urquhart reports that with the growing gene therapy development pipeline comes the need for manufacturing capacity. Will biopharma firms buy or build? Buy will often be the answer when feasible. The $1.2 billion all cash deal represents a considerable premium....
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
